86 related articles for article (PubMed ID: 4944363)
21. [L-asparaginases from Escherichia coli. I. Properties of the native forms].
Laboureur P; Langlois C; Labrousse M; Boudon M; Emeraud J; Samain JF; Ageron M; Dumesnil Y
Biochimie; 1971; 53(11):1147-56. PubMed ID: 4949107
[No Abstract] [Full Text] [Related]
22. [L-asparaginases from Escherichia coli. I. Properties of the native forms].
Laboureur P; Langlois C; Labrousse M; Boudon M; Emeraud J; Samain JF; Ageron M; Dumesnil Y
Biochimie; 1971; 53(11):1147-56. PubMed ID: 4948670
[No Abstract] [Full Text] [Related]
23. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
Terent'eva TG; Sokolov AB; Navashin SM
Antibiotiki; 1977 Jan; 22(1):78-81. PubMed ID: 320935
[TBL] [Abstract][Full Text] [Related]
24. A comparison of Erwinia carotovora and Escherichia coli L-asparaginases and their subunits.
Miller DS; Marlborough DI; Cammack KA
J Gen Microbiol; 1971 Mar; 65(3):ii. PubMed ID: 4933808
[No Abstract] [Full Text] [Related]
25. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
[TBL] [Abstract][Full Text] [Related]
26. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic and ultrastructural studies of L-asparaginase-induced hypocalcemia in rabbits. An experimental animal model of acute hypoparathyroidism.
Young DM; Olson HM; Prieur DJ; Cooney DA; Reagan RL
Lab Invest; 1973 Oct; 29(4):374-86. PubMed ID: 4598146
[No Abstract] [Full Text] [Related]
28. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
[TBL] [Abstract][Full Text] [Related]
29. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
[TBL] [Abstract][Full Text] [Related]
30. The partitioning of L-asparaginase between blood and lymph.
Hall JG
Recent Results Cancer Res; 1970; 33():75-80. PubMed ID: 4949170
[No Abstract] [Full Text] [Related]
31. The toxicity of Escherichia coli L-asparaginase.
Schein PS; Rakieten N; Gordon BM; Davis RD; Rall DP
Cancer Res; 1969 Feb; 29(2):426-34. PubMed ID: 4975316
[No Abstract] [Full Text] [Related]
32. Purification and preliminary characterization of L-asparaginase from Erwinia aroideae NRRL B-138.
Tiwari N; Dua RD
Indian J Biochem Biophys; 1996 Oct; 33(5):371-6. PubMed ID: 9029817
[TBL] [Abstract][Full Text] [Related]
33. Automated determination of bacterial asparaginase and glutaminase.
Wade HE; Phillips BP
Anal Biochem; 1971 Nov; 44(1):189-99. PubMed ID: 4943713
[No Abstract] [Full Text] [Related]
34. Improvement in the persistence of microbial asparaginase and glutaminase in the circulation of the rat by chemical modifications.
Blazek R; Benbough JE
Biochim Biophys Acta; 1981 Oct; 677(2):220-4. PubMed ID: 6794649
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
[TBL] [Abstract][Full Text] [Related]
36. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
Uren JR; Hargis BJ; Beardsley P
Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
[TBL] [Abstract][Full Text] [Related]
37. Enzyme therapy: problems and solutions.
Holcenberg JS
Annu Rev Biochem; 1982; 51():795-812. PubMed ID: 6810751
[No Abstract] [Full Text] [Related]
38. Microcalorimetric determination of substrate specificity of L-asparaginase in Escherichia coli and Erwinia carotovora.
Rekharsky MV; Egorov AM; Bankovskaya SA; Ozoliņa RK; Vĩna IA; Berziņa-Berzĩte RV; Lopatnev SV; Galchenko GL
J Biochem Biophys Methods; 1988 Aug; 16(4):319-21. PubMed ID: 3065395
[No Abstract] [Full Text] [Related]
39. Proteins from Erwinia asparaginase Erwinase ® and E. coli asparaginase 2 MEDAC ® for treatment of human leukemia, show a multitude of modifications for which the consequences are completely unclear.
Bae N; Pollak A; Lubec G
Electrophoresis; 2011 Jul; 32(14):1824-8. PubMed ID: 21769889
[TBL] [Abstract][Full Text] [Related]
40. [L-asparaginases from Escherichia coli. II. Plurality and origin of molecular forms. Relations with the biological activity].
Laboureur P; Langlois C; Labrousse M; Boudon M; Emeraud J; Samain JF; Ageron M; Dumesnil Y
Biochimie; 1971; 53(11):1157-65. PubMed ID: 4948671
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
